Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer's disease.
Level 5 - mechanism / opinion, no new human data
Narrative review of mechanistic and preclinical/clinical literature without systematic search methodology.
PubMed 18647624 · doi:10.1016/j.addr.2008.06.003
What was done
This narrative review synthesized experimental and clinical literature on estrogen signaling pathways in hippocampal and cortical neurons, focusing on mitochondrial regulation, glucose metabolism, and implications for Alzheimer's disease prevention.
What was found
The abstract provides no numerical data, effect sizes, or study counts. It qualitatively reports that estrogen supports aerobic glycolysis, oxidative phosphorylation, ATP generation, calcium homeostasis, and beta-amyloid clearance in healthy neurons. However, in degenerating neurons, estrogen may exacerbate neurological demise through dysregulated calcium load, leading to the 'healthy cell bias' hypothesis where benefits depend on baseline neuronal health.
Why it matters
The paper provides a mechanistic framework to explain conflicting outcomes in hormone therapy trials, proposing that neuroprotection requires early intervention before neurodegenerative damage is established.
Limits
The abstract reports no primary clinical data, quantitative results, or systematic review methodology. Hypothesized pathways and the 'healthy cell bias' model rely heavily on mechanistic reasoning and mixed experimental models.
Cited by
- supports Estradiol specifically is critical for the brain's ability to utilize glucose for energy, and reductions in estradiol during perimenopause and menopause impair brain energy metabolism.